A Telethon Kids Institute Research study examining drug resistance in leukaemia patients has shed new light on why some treatments may be more effective than others.

The study, which looked at cells from children suffering from T-cell acute lymphoblastic leukaemia (T-ALL), examined how different genes were associated with resistance to different drugs in an effort to improve treatment success.